Human herpesvirus 6 infection in adult living related liver transplant recipients

Liver Transplantation

Volumn 14, Issue 1, 2008, Pages 100-109

  Ohashi, Masahiro ^a   Sugata, Ken ^a   Ihira, Masaru ^a   Asano, Yoshizo ^a   Egawa, Hiroto ^b   Takada, Yasutsugu ^b   Uemoto, Shinji ^b   Yoshikawa, Tetsushi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMINOTRANSFERASE; ANTIBIOTIC AGENT; COTRIMOXAZOLE; CYTOKINE; GANCICLOVIR; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; MICONAZOLE; OKT 3; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS C; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; VIREMIA; VIROLOGY; VIRUS ISOLATION; VIRUS REACTIVATION;

ADULT; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOASSAY; INCIDENCE; INTERLEUKIN-6; JAPAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS; VIREMIA;

EID: 38649122745     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21304     Document Type: Article

References (49)

1. Razonable RR, Paya CV. The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation. Liver Transpl 2002;8:651-658.
2. Yoshikawa T. Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant 2003;7:11-17.
3. Ward KN, Gray JJ, Efstathiou S. Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 1989;28:69-72.
4. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997; 64:674-678.
5. Yoshikawa T, Ihira M, Furukawa H, Suga S, Asonuma K, Tanaka K, et al. Four cases of human herpesvirus 6 variant B infection after pediatric liver transplantation. Transplantation 1998;65:1266-1269.
6. Yoshikawa T, Ihira M, Suzuki K, Suga S, Iida K, Saito Y, et al. Human herpesvirus 6 infection after living related liver transplantation. J Med Virol 2000;62:52-59.
7. Rogers J, Rohal S, Carrigan DR, Kusne S, Knox KK, Gayowski T, et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000;69:2566-2573.
8. Yoshikawa T, Ihira M, Suzuki K, Suga S, Asano Y, Asonuma K, et al. Primary human herpesvirus 6 infection in liver transplant recipients. J Pediatr 2001;138:921-925.
9. Singh N, Husain S, Carrigan DR, Knox KK, Weck KE, Wagener MM, et al. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 2002; 16:92-96.
10. Lautenschlager I, Hockerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998;26:702-707.
11. Lautenschlager I, Hockerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Transplantation 2000;69:2561-2566.
12. Lautenschlager I, Lappalainen M, Linnavuori K, Suni J, Hockerstedt K. CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients. J Clin Virol 2002;25(suppl 2):S57-S61.
13. Cervera C, Marcos MA, Linares L, Roig E, Benito N, Pumarola T, et al. A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients. Transplantation 2006;82:979-982.
14. Harma M, Hockerstedt K, Krogerus L, Lautenschlager I. Pretransplant human herpesvirus 6 infection of patients with acute liver failure is a risk factor for posttransplant human herpesvirus 6 infection of the liver. Transplantation 2006;81:367-372.
15. Dockrell DH, Prada J, Jones MF, Patel R, Badley AD, Harmsen WS, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997;176:1135-1140.
16. Dockrell DH, Mendez JC, Jones M, Harmsen WS, Ilstrup DM, Smith TF, et al. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation 1999;67:399-403.
17. DesJardin JA, Cho E, Supran S, Gibbons L, Werner BG, Snydman DR. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. Clin Infect Dis 2001;33:1358-1362.
18. Humar A, Kumar D, Caliendo AM, Moussa G, Ashi-Sulaiman A, Levy G, et al. Clinical impact of human herpesvirus 6 infection after liver transplantation. Transplantation 2002;73:599-604.
19. Humar A, Kumar D, Raboud J, Caliendo AM, Moussa G, Levy G, et al. Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation. Am J Transplant 2002;2:461-466.
20. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV, and the PV16000 Study Group. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 2005;192: 1331-1339.
21. Hasegawa T, Kimura T, Sasaki T, Okada A, Tanaka-Taya K, Miyagawa H, et al. Sequential measurement of human herpesvirus 6 DNA with polymerase chain reaction method in pediatric living-related liver transplantation. Clin Transplant 2001;15:208-213.
22. Feldstein AE, Razonable RR, Boyce TG, Freese DK, El-Youssef M, Perrault J, et al. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant 2003;7: 125-129.
23. Montejo M, Ramon Fernandez J, Testillano M, Valdivieso A, Aguirrebengoa K, Varas C, et al. Encephalitis caused by human herpesvirus-6 in a liver transplant recipient. Eur Neurol 2002;48:234-235.
24. Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991;72:1401-1408.
25. Suga S, Yoshikawa T, Kajita Y, Ozaki T, Asano Y. Prospective study of persistence and excretion of human herpesvirus-6 in patients with exanthem subitum and their parents. Pediatrics 1998;102:900-904.
26. Yoshikawa T. Human herpesvirus 6 infection in hematopoietic stem cell transplant patients. Br J Haematol 2004; 124:421-432.
27. Docke WD, Prosch S, Fietze E, Kimel V, Zuckermann H, Klug C, et al. Cytomegalovirus reactivation and tumor necrosis factor. Lancet 1994;343:268-269.
28. Fietze E, Prosch S, Reinke P, Stein J, Docke WD, Staffa G, et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994; 58:675-680.
29. Simon CO, Seckert CK, Dreis D, Reddehase MJ, Grzimek NK. Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 2005;79:326-340.
30. Yoshikawa T, Fujita A, Yagami A, Suzuki K, Matsunaga K, Ihira M, et al. Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome. J Clin Virol 2006; 37(suppl 1):S92-S96.
31. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-1115.
32. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999;37:132-136.
33. Yoshikawa T, Suga S, Asano Y, Yazaki T, Kodama H, Ozaki T. Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus-6) in healthy individuals. Pediatrics 1989;84:675-677.
34. Tanaka N, Kimura H, Hoshino Y, Kato K, Yoshikawa T, Asano Y, et al. Monitoring four herpesviruses in unrelated cord blood transplantation. Bone Marrow Transplant 2000;26:1193-1197.
35. Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44:489-501.
36. Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, et al. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients. Transplantation 2006;81:350-354.
37. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995;85:1263-1271.
38. Gobbi A, Stoddart CA, Malnati MS, Locatelli G, Santoro F, Abbey NW, et al. Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J Exp Med 1999;189:1953-1960.
39. Smith A, Santoro F, Di Lullo G, Dagna L, Verani A, Lusso P. Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003;102:2877-2884.
40. Smith AP, Paolucci C, Di Lullo G, Burastero SE, Santoro F, Lusso P. Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J Virol 2005;79:2807-2813.
41. Rosen HR, Chou S, Corless CL, Gretch DR, Flora KD, Boudousquie A, et al. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997;64:721-726.
42. Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, et al. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis 2002;35:974-981.
43. Kallinowski B, Haseroth K, Marinos G, Hanck C, Stremmel W, Theilmann L, et al. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998;111:269-277.
44. Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L Jr, et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 2003;170:5615-5624.
45. Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, et al. Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts. J Infect Dis 2002;185:110-113.
46. Desachy A, Ranger-Rogez S, Francois B, Venot C, Traccard I, Gastinne H, et al. Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. Clin Infect Dis 2001;32:197-203.
47. Flamand L, Gosselin J, D'Addario M, Hiscott J, Ablashi DV, Gallo RC, et al. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 1991;65:5105-5110.
48. Gosselin J, Flamand L, D'Addario M, Hiscott J, Stefanescu I, Ablashi DV, et al. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J Immunol 1992;149:181-187.
49. Mayne M, Cheadle C, Soldan SS, Cermelli C, Yamano Y, Akhyani N, et al. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J Virol 2001;75: 11641-11650.